Keywords
MedicineCaptoprilPlaceboMyocardial infarctionCardiogenic shockBolus (digestion)Randomized controlled trialHeart failureInternal medicineAnesthesiaSurgeryBlood pressure
Related Publications
Use of Emergency Medical Services in Acute Myocardial Infarction and Subsequent Quality of Care
Background— National practice guidelines strongly recommend activation of the 9-1-1 Emergency Medical Systems (EMS) by patients with symptoms consistent with an acute myocardial...
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
17,187 patients entering 417 hospitals up to 24 hours (median 5 hours) after the onset of suspected acute myocardial infarction were randomised, with placebo control, between: (...
Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis
Background: There is controversy about the outcome of patients with acute myocarditis (AM), and data are lacking on how patients admitted with suspected AM are managed. We repor...
Decline in Rates of Death and Heart Failure in Acute Coronary Syndromes, 1999-2006
In this multinational observational study, improvements in the management of patients with ACS were associated with significant reductions in the rates of new heart failure and ...
Publication Info
- Year
- 1995
- Type
- article
- Volume
- 345
- Issue
- 8951
- Pages
- 669-685
- Citations
- 1816
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1816
OpenAlex
Cite This
(1995).
ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction.
The Lancet
, 345
(8951)
, 669-685.
https://doi.org/10.1016/s0140-6736(95)90865-x
Identifiers
- DOI
- 10.1016/s0140-6736(95)90865-x